Regulation of xenogeneic porcine pancreatic islets

Xenotransplantation

Volumn 17, Issue 5, 2010, Pages 329-337

  Arcidiacono, Judith A ^a   Evdokimov, Evgenij ^b   Lee, Mark H ^a   Jones, Jeff ^b   Rudenko, Larisa ^b   Schneider, Bruce ^a   Snoy, Phillip J ^a   Wei, Cheng Hong ^a   Wensky, Allen K ^a   Wonnacott, Keith ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

diabetes; FDA; pancreatic islets; porcine; regulation

Indexed keywords

CELL ENCAPSULATION; CLINICAL TRIAL; FOOD AND DRUG ADMINISTRATION; GENETIC ENGINEERING; HUMAN; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SWINE; UNITED STATES; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CLINICAL TRIALS AS TOPIC; GUIDELINES AS TOPIC; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; ZOONOSES;

EID: 78349274459     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2010.00592.x     Document Type: Review

References (19)

1. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402-1404.
2. PHS Guideline on Infectious Disease Issues in Xenotransplantation. Available at: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Xenotransplantation/ucm074727. htm, 2001 [accessed on 12 April 2010].
3. Guidance for Industry: Source Animals, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Human. Available at: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Xenotransplantation/ucm074354. htm, 2003 [accessed on 12 April 2010].
4. Draft Guidance for Industry: Precautionary Measures to Reduce the Possible Risk of Transmission of Zoonoses by Blood and Blood Products from Xenotransplantation Product Recipients and Their Intimate Contacts. Available at: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm075122.htm, 2002 [accessed on 12 April 2010].
5. Guidance for Industry: Public Health Issues Posed by the Use of Non-Human Primate Xenografts in Humans. Available at: http://www.fda.gov/ BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/ Xenotransplantation/ucm074730.htm, 1999 [accessed on 12 April 2010].
6. First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19-21 November 2008. The Changsha Communiqué. Xenotransplantation 2009; 16: 61-63.
7. Bas-Bernardet SL, Anegon I, Blancho G,. Progress and prospects: genetic engineering in xenotransplantation. Gene Ther 2008; 15: 1247-1256.
8. Rood PPM, Buhler LH, Bottino R, Trucco M, Cooper DKC,. Pig-to-nonhuman primate islet xenotransplantation: a review of current problems. Cell Transplant 2006; 15: 89-104.
9. Komoda H, Miyagawa S, Omori T, et al. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys. Xenotransplantation 2005; 12: 209-216.
10. Mandel TE, Koulmanda M, Cozzi E, et al. Transplantation of normal and DAF-transgenic fetal pig pancreas into cynomolgus monkeys. Transplant Proc 1997; 29: 940.
11. Milland J, Christiansen D, Lazarus BD, Taylor SG, Xang PX, Sandrin MS,. The molecular basis for gal-alpha (1,3) gal expression in animals with a deletion of the alpha-1,3-galactosyltransferase gene. J Immunol 2006; 176: 2448-2454.
12. Regulation of Genetically Engineered Animals Containing Heritable rDNA Constructs. Available at: http://www.fda.gov/downloads/AnimalVeterinary/ GuidanceComplianceEnforcement/GuidanceforIndustry/UCM113903.pdf, 2009 [accessed on 12 April 2010].
13. ASTM Standard F2064-00, 2006e1, Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Products Application. ASTM International, West Conshohocken, PA, 2006, DOI: DOI:10.1520/F2064-00R06E01, www.astm.org, [accessed on 12 April 2010].
14. ASTM Standard F2315-03, 2003, Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels, ASTM International, West Conshohocken, PA, 2003, DOI: 10.1520/F2315-03, www.astm.org, [accessed on 12 April 2010].
15. Dornish M, Kaplan D, Skaugrud O,. Standards and guidelines for biopolymers in tissue-engineered medical products: ASTM alginate and chitosan standard guides. American Society for Testing and Materials. Ann N Y Acad Sci 2001; 944: 388-397.
16. Animal Models for Porcine Xenotransplantation Products Intended to Treat Type 1 Diabetes or Acute Liver Failure. Available at: http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapies, May 14, 2009. [accessed on 12 April 2010].
17. Hering B, Cooper DKC, Cozzi E, et al. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes. Xenotransplantation 2009; 16: 196-202.
18. Collaborative Islet Transplant Registry Annual Report. Available at: https://web.emmes.com/study/isl/reports/091508CITR5thAnnualReport-revision%201. 5.pdf, 2008. [accessed on 12 April 2010].
19. Guidance for Industry: Considerations for Allogeneic Pancreatic Islet Cell Products. Available at: http://www.fda.gov/downloads/ BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/ CellularandGeneTherapy/UCM182441.pdf, 2009. [accessed on 12 April 2010].